Table 1 Patient characteristics and the SLC25A43 expression in the HER2-positive breast cancer cohort
Parameters | No. of cases total in the cohort (%) | Mean values of total cases in the cohort | SLC25A43 expression | P-value | |
|---|---|---|---|---|---|
| Ā | Ā | Ā | Negative/Low | Medium/High | Ā |
All | 85 | Ā | 26 | 45 | Ā |
Patient's age | Ā | Ā | Ā | Ā | Ā |
āāā¤50āyears | 22 (26) | Ā | Ā | Ā | Ā |
āā>50āyears | 62 (73) | Ā | Ā | Ā | Ā |
āāMean age (years) | Ā | 58.5 | 62 | 58 | 0.269 |
āāND | 1 (1) | Ā | Ā | Ā | Ā |
Tumour size | Ā | Ā | Ā | Ā | Ā |
āāā¤2ācm | 33 (39) | Ā | Ā | Ā | Ā |
āā>2ācm | 50 (59) | Ā | Ā | Ā | Ā |
āāMean size (mm) | Ā | 28 | 25 | 30 | 0.13 |
āāND | 2 (2) | Ā | Ā | Ā | Ā |
S-phase | Ā | Ā | Ā | Ā | Ā |
āāInclude cases | 70 (82) | Ā | Ā | Ā | Ā |
āāMean S-phase (%) | Ā | 10.7 | 9.4 | 12.6 | 0.024 |
āāND | 15 (18) | Ā | Ā | Ā | Ā |
LN metastasis | Ā | Ā | Ā | Ā | Ā |
āāNegative | 27 (32) | Ā | 8 | 15 | 0.859 |
āāPositive | 55 (65) | Ā | 17 | 29 | Ā |
āāND | 3 (4) | Ā | Ā | Ā | Ā |
ER status | Ā | Ā | Ā | Ā | Ā |
āāNegative | 38 (45) | Ā | 12 | 20 | 0.951 |
āāPositive | 41 (48) | Ā | 13 | 21 | Ā |
āāND | 6 (7) | Ā | Ā | Ā | Ā |
PgR status | Ā | Ā | Ā | Ā | Ā |
āāNegative | 45 (53) | Ā | 16 | 24 | 0.659 |
āāPositive | 33 (39) | Ā | 9 | 17 | Ā |
āāND | 7 (8) | Ā | Ā | Ā | Ā |